Hence, in order to deliver insulin with high efficacy to the brain, for the treatment of Alzheimer’s disease, Nojoki et al. [108] encapsulated it inside transfersomes for intranasal delivery. This evidence concerns the gene INS and early-onset autosomal dominant Alzheimer disease.